Daniel Patrick O'Day

Chairman & CEO, Director, Gilead Sciences

Bought, 12 months

$0.0M

Sold, 12 months

$51.2M

Companies

Latest trade

Oct 1, 2026

Companies

Gilead SciencesChairman & CEO, Director −$52.4M

Trades

GILD Sold 15,000 shares at $147.90 · planned $2.2M Oct 1

GILD Sold 15,000 shares at $148.64 · planned $2.2M Sep 1

GILD Sold 15,000 shares at $130.31 · planned $2.0M Aug 3

GILD Sold 15,000 shares at $126.29 · planned $1.9M Jul 1

GILD Sold 15,000 shares at $131.46 · planned $2.0M Jun 1

GILD Sold 10,000 shares at $129.16 · planned $1.3M Apr 28

GILD Sold 10,000 shares at $136.82 · planned $1.4M Mar 27

GILD Sold 10,000 shares at $144.79 · planned $1.4M Feb 27

GILD Sold 115,640 shares at $150.00 · planned $17.3M Feb 5

GILD Sold 10,000 shares at $139.89 · planned $1.4M Jan 28

GILD Sold 115,640 shares at $135.00 · planned $15.6M Jan 23

GILD Sold 10,000 shares at $124.83 · planned $1.2M Dec 29

GILD Sold 10,000 shares at $126.54 · planned $1.3M Nov 28

GILD Sold 10,000 shares at $119.39 · planned $1.2M Oct 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.